hotspot -WSS

hotspot

author：comprehensive 2025-09-29 01:09:08 - browse：2235

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： The biotech scorecard for Q4: 16 stock

hotspot

WSS

Climate activists disrupt London Pride march to protest corporate sponsorship

Health insurers' Q3 question: how much care are people getting?

Slain Parkland victim's father speaks out following reenactment

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

New company forms to vet health AI models, root out weaknesses

entertainment

hotspot

explore

Medical leaders decry Supreme Court decision on affirmative action

Special counsel alerts court to Trump’s social media post

At least 13 dead in Texas as scorching temps continue

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Lawsuit highlights wrinkle for disputes over surprise medical bills

In age of alternative facts, a scholarly course on calling out crap

European officials brace for rough respiratory virus season

Duchenne breakthrough therapy leaves behind pioneering families

What will Novo Nordisk's VC do with its influx of cash?

entertainment

CRISPR base editing slashes cholesterol levels in monkeys

The Karikó problem: Lessons for funding basic research

Health insurers' Q3 question: how much care are people getting?

Lawsuit highlights wrinkle for disputes over surprise medical bills

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Study points to new risk in gene therapy death of Terry Horgan

entertainment

hotspot

hotspot

hotspot